Title:
認知症における認知機能改善用組成物
Document Type and Number:
Japanese Patent JP6940109
Kind Code:
B2
Abstract:
The present invention pertains to a composition that is for ameliorating brain functions and that contains coral calcium, a cinnamic acid derivative compound, and a nicotine amide derivative.
More Like This:
| WO/2017/073473 | MORINGA EXTRACT |
| JP2016073326 | COACERVATE COMPLEXES, METHODS AND FOOD PRODUCTS |
| JP2016104710 | TABLET OR CAPSULE MOLDED PRODUCT |
Inventors:
Toru Hasegawa
Application Number:
JP2020519884A
Publication Date:
September 22, 2021
Filing Date:
May 15, 2019
Export Citation:
Assignee:
Mrd Inc.
Aika Co., Ltd.
Aika Co., Ltd.
International Classes:
A23L33/10; A23L33/105; A23L33/16; A61K31/01; A61K31/192; A61K31/455; A61K31/7084; A61K33/00; A61K35/614; A61P25/28
Foreign References:
| WO2015016285A1 |
Other References:
ANDERSON, D. W., BRADBURY, K. A., and SCHNEIDER, J. S.,Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism,European Journal of Neuroscience,2008年,Vol.28,p.610-617
HOU, Yujun et al.,NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency,PNAS,2018年 2月 5日,E1876-E1885
History of Changes for Study: NCT03462680,ClinicalTrials.gov archive,2018年 3月 5日,v1,p.1-8
MORRIS, M. C. et al.,Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline,J. Neurol. Neurosurg. Psychiatry,2004年,Vol.75,p.1093-1099
HOU, Yujun et al.,NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency,PNAS,2018年 2月 5日,E1876-E1885
History of Changes for Study: NCT03462680,ClinicalTrials.gov archive,2018年 3月 5日,v1,p.1-8
MORRIS, M. C. et al.,Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline,J. Neurol. Neurosurg. Psychiatry,2004年,Vol.75,p.1093-1099
Attorney, Agent or Firm:
Norihito Yamao
Nagatoshi Shinagawa
Nagatoshi Shinagawa